---
title: The chromatin accessibility landscape of chronic lymphocytic leukemia
author:
        - André F. Rendeiro^1^^,^^\*^
        - Christian Schmidl^1^^,^^\*^
        - David Oscier^2^
        - Jonathan Strefford^3^
        - Christoph Bock^1^^,^^4^^,^^5^^,^^6^
        - ^1^CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
        - ^2^Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom
        - ^3^Cancer Genomics, Cancer Sciences, University of Southampton, Southampton, United Kingdom
        - ^4^Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
        - ^5^Max Planck Institute for Informatics, Saarbrücken, Germany
        - ^6^Correspondence should be addressed to C.B. (<cbock@cemm.oeaw.ac.at>)
        - ^\*^equal contribution
tags: [chronic lymphocytic leukaemia, chromatin, ATAC-seq]
bibliography: /home/afr/Documents/library.bib
---

Citing works like this [@Puente2015]

## Abstract
250 words or fewer

## Introduction
## Methods
## Results
##### uCLL vs mCLL

*De novo* motif analysis on differentially open chromatin site between uCLL and mCLL show enrichemnt for the PAX5 transcription factor (TF) [doi:10.1038/ni1454](http://dx.doi.org/doi:10.1038/ni1454).


The Forkhead transcription factor (TF) FOXO1 is also enriched, known to play a role in B cell and highly expressed in CD19+ B-cells, naive and memory and in cases of CLL [10.1182/blood-2011-09-381905](http://dx.doi.org/10.1182/blood-2011-09-381905). Interestingly, this TF seems to be a tumor supressor in classical Hodgkin lymphoma.
Its role in CLL is yet illusive.


Go term enrichment:
"Rho guanyl-nucleotide exchange factor activity" and
"GTPase binding" -> proliferation [doi:10.1038/onc.2013.362](http://dx.doi.org/doi:10.1038/onc.2013.362)

"positive regulation of interleukin-2 biosynthetic process" -> [doi:10.1038/312641a0](http://dx.doi.org/doi:10.1038/312641a0)


## Discussion
## Acknowledgements
## Authorship Contributions
## Disclosure of Conflicts of Interest
## Tables
## Figure Legends
## Figures
![](figures/fig01.png){width=75%}

## Supplemental data

## References
